for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-NGM Bio Reports Q4 Net Loss Per Share Of $0.24

March 17 (Reuters) - NGM Biopharmaceuticals Inc:

* NGM BIO REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

* NGM BIOPHARMACEUTICALS - QTRLY NET LOSS PER SHARE $0.24

* NGM BIOPHARMACEUTICALS - QTRLY RELATED PARTY REVENUE FROM COLLABORATION WITH MERCK WAS $31.1 MILLION VERSUS $47.1 MILLION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up